Identifying Generic Market Drivers for CII Products

IndustryPharmaceutical Manufacturer
ProblemThe manufacturer of a Schedule II Controlled Substance (CII) wanted to understand pharmacy product selection for CII products.
PHSI SolutionPHSI identified several issues that could slow brand to generic conversions. PHSI surveyed fifty pharmacists in outpatient pharmacy practice settings including chain, regional chain, supermarket, independent, and mass merchant pharmacies in order to assess generic product availability, reasons for not substituting a generic for a brand product, and pharmacist preference for brand versus generic.
ResultsThe survey found that patients and physicians, not pharmacists, drove product substitution for CII products. PHSI created a matrix to display survey results. The manufacturing client commented on PHSI’s superior ability to reach out to top pharmacy chains and to facilitate their strategic decision making.